NL-OMON27507尚未招募不适用
B-cell depletion with Rituximab for Dose reduction of Glucocorticoids: Efficacy in PolyMyalgia Rheumatica
one. This is an investigator initiated trial0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •·PMR according to the Chuang PMR classification criteria
- •·Signed written informed consent
排除标准
- •·Not being able to speak, read or write Dutch
- •·PMR diagnosed >4 weeks before inclusion in the study
研究者
相似试验
招募中
不适用
Influence of B cell depletion therapy (rituximab) on (risk factors of) comorbidity in rheumatoid arthritisrheumatoid arthritis100822061000381610023213NL-OMON31299Vrije Universiteit Medisch Centrum50
已完成
2 期
Effect of B-cell Depletion in Patients With Primary Sjögren's SyndromePrimary Sjögren's SyndromeHyposalivationFatigueXerostomiaKeratoconjunctivitis SiccaNCT00426543University of Copenhagen21
进行中（未招募）
不适用
Efficacy of B-cell depletion with rituximab on oral, ocular and general disease manifestations in patients with primary Sjögren diseasePreviously treated patients with primary Sjögrens diseaseMedDRA version: 8.0Level: PTClassification code 10040767EUCTR2005-004740-31-DKniversity of Copenhagen34
Unknown
4 期
RituxiMab INDuction in Renal TransplantationFunction of Renal TransplantNCT01095172Guy's and St Thomas' NHS Foundation Trust100
尚未招募
2 期
Cure rate of childhood B cell lymphoma with rituximab and reduced strength of chemotherapyCTRI/2017/09/009650Cancer Institute adyar